Details of the Drug Formulaction

General Information of Drug Formulation (ID: F01583)

• Formulation Name: Aspirin 325 mg tablet
• Company: Aidarex Pharmaceuticals; Aphena Pharma Solutions-Tennessee; Clinical Solutions Wholesale; Contract Pharmacal; H. J. Harkins Company; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Major Pharmaceuticals; NCS HealthCare of KY, Inc dba Vangard Labs; Proficient Rx; Rebel Distributors; RemedyRepack; Rugby Laboratories

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Aspirin	(DM672AH)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent